Director, Global Clinical Program Leader, Immunoglobulins
CSL Innovation(2 months ago)
About this role
Director of Clinical Program, Immunoglobulins at CSL Behring will lead clinical strategy for immunoglobulin development programs within the company’s R&D organization. The role is based in King of Prussia, PA; Waltham, MA; Maidenhead, UK; or Zurich, Switzerland and is a hybrid position requiring onsite presence three days per week. The position operates in a project-led, collaborative biotech environment focused on developing innovative therapies for patients worldwide.
Required Skills
- Clinical Development
- Medical Monitoring
- Regulatory Submissions
- Protocol Design
- Program Leadership
- Stakeholder Management
- GCP Compliance
- ICH Guidelines
- Clinical Writing
- Project Management
Qualifications
- MD
- PhD
- Board Certified
About CSL Innovation
csl.comCSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.
View more jobs at CSL Innovation →Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at CSL Innovation
Similar Jobs
Global Country Safety Specialist
Premier Research(11 days ago)
Clinical Research Associate
Clinical Careers Page(2 months ago)
Clinical Trial Manager - UK or Italy (Remote) - FSP
Parexel(2 months ago)
Clinical Research Associate - IQVIA BIOTECH (homebased in France)
IQVIA(2 months ago)
Clinical Trial Manager II, IQVIA Biotech
IQVIA(1 month ago)
Associate Director, Regulatory CMC
Dyne Therapeutics(2 months ago)